Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5.
D'Esposito V, Liguoro D, Ambrosio MR, Collina F, Cantile M, Spinelli R, Raciti GA, Miele C, Valentino R, Campiglia P, De Laurentiis M, Di Bonito M, Botti G, Franco R, Beguinot F, Formisano P. D'Esposito V, et al. Among authors: de laurentiis m. Oncotarget. 2016 Apr 26;7(17):24495-509. doi: 10.18632/oncotarget.8336. Oncotarget. 2016. PMID: 27027351 Free PMC article.
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype.
Capasso I, Esposito E, de Laurentiis M, Maurea N, Cavalcanti E, Botti G, Petrillo A, Montella M, D'Aiuto M, Coppola C, Crispo A, Grimaldi M, Frasci G, Fucito A, Ciliberto G, D'Aiuto G. Capasso I, et al. Among authors: de laurentiis m. Diabetol Metab Syndr. 2014 Sep 26;6(1):105. doi: 10.1186/1758-5996-6-105. eCollection 2014. Diabetol Metab Syndr. 2014. PMID: 25285159 Free PMC article.
Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?
Criscitiello C, Giuliano M, Curigliano G, De Laurentiis M, Arpino G, Carlomagno N, De Placido S, Golshan M, Santangelo M. Criscitiello C, et al. Among authors: de placido s, de laurentiis m. Eur J Surg Oncol. 2015 Oct;41(10):1288-92. doi: 10.1016/j.ejso.2015.07.013. Epub 2015 Jul 29. Eur J Surg Oncol. 2015. PMID: 26238477 Review.
Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer.
Collina F, Di Bonito M, Li Bergolis V, De Laurentiis M, Vitagliano C, Cerrone M, Nuzzo F, Cantile M, Botti G. Collina F, et al. Among authors: de laurentiis m. Biomed Res Int. 2015;2015:158682. doi: 10.1155/2015/158682. Epub 2015 Oct 4. Biomed Res Int. 2015. PMID: 26504780 Free PMC article.
Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort.
D'Aiuto M, Chirico A, De Riggi MA, Frasci G, De Laurentiis M, Di Bonito M, Vici P, Pizzuti L, Sergi D, Maugeri-Saccà M, Barba M, Giordano A. D'Aiuto M, et al. Among authors: de riggi ma, de laurentiis m. Cancer Biol Ther. 2016 May 3;17(5):470-6. doi: 10.1080/15384047.2016.1156265. Epub 2016 Mar 2. Cancer Biol Ther. 2016. PMID: 26934127 Free PMC article.
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
Crispo A, Montella M, Buono G, Grimaldi M, D'Aiuto M, Capasso I, Esposito E, Amore A, Nocerino F, Augustin LS, Giudice A, Di Bonito M, Giuliano M, Forestieri V, De Laurentiis M, Rinaldo M, Ciliberto G, De Placido S, Arpino G. Crispo A, et al. Among authors: de placido s, de laurentiis m. Curr Res Transl Med. 2016 Jan-Mar;64(1):15-20. doi: 10.1016/j.retram.2016.01.004. Epub 2016 Mar 2. Curr Res Transl Med. 2016. PMID: 27140595
Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.
Crispo A, Augustin LS, Grimaldi M, Nocerino F, Giudice A, Cavalcanti E, Di Bonito M, Botti G, De Laurentiis M, Rinaldo M, Esposito E, Riccardi G, Amore A, Libra M, Ciliberto G, Jenkins DJ, Montella M. Crispo A, et al. Among authors: de laurentiis m. J Cell Physiol. 2017 May;232(5):1144-1150. doi: 10.1002/jcp.25579. Epub 2016 Sep 30. J Cell Physiol. 2017. PMID: 27579809
Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients.
Botti G, Collina F, Scognamiglio G, Rao F, Peluso V, De Cecio R, Piezzo M, Landi G, De Laurentiis M, Cantile M, Di Bonito M. Botti G, et al. Among authors: de cecio r, de laurentiis m. Int J Mol Sci. 2017 Feb 21;18(2):459. doi: 10.3390/ijms18020459. Int J Mol Sci. 2017. PMID: 28230773 Free PMC article.
275 results